MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    The effect of subthalamic deep brain stimulation on response inhibition and voluntary action control depend on connectivity of the volume of activated tissue with the prefrontal cortex

    J. Waldthaler, A. Sperlich, C. Stüssel, K. Steidel, L. Timmermann, D. Pedrosa (Marburg, Germany)

    Objective: The effect of subthalamic deep brain stimulation on response inhibition and voluntary action control depend on connectivity of the volume of activated tissue with…
  • 2023 International Congress

    No laughing white matter: reduced integrity of the lateral nucleus basalis of Meynert pathway in Parkinson’s disease-related cognitive impairment

    R. Crockett, K. Wilkins, S. Aditham, H. Bronte-Stewart (Stanford, USA)

    Objective: Investigate differences in white matter integrity of the nucleus basalis of Meynert (NBM) tracts in Parkinson’s disease (PD) patients who develop mild cognitive impairment…
  • 2023 International Congress

    What change to expect in duration of benefit per dose when switching from IR CD-LD to IPX203 (ER CD-LD)

    R. Hauser, S. Allard, G. Banisadr, S. Fisher (Tampa, USA)

    Objective: To investigate if duration of benefit (“Good On” time) per dose during immediate-release (IR) carbidopa-levodopa (CD-LD) treatment predicts response to IPX203 conversion. Background: Levodopa’s…
  • 2023 International Congress

    How do recently diagnosed individuals with Parkinson’s self-monitor their Parkinson’s symptoms between consultations?

    J. Domingos, J. Dean, C. Godinho, J. Belo, S. Gow, D. Falconer (Nijmegen, Netherlands)

    Objective: To determine how recently diagnosed people with Parkinson's monitor their Parkinson's symptoms in between medical consultations. Background: Patients monitoring symptoms and reporting them accurately…
  • 2023 International Congress

    How do people with Parkinson’s disease experience self-optimization of treatment using digitally supported symptom monitoring?

    K. Fåglum, A. Hjorth, M. Christani, P. Hagell, A. Ozanne, F. Bergquist (Varberg, Sweden)

    Objective: The aim of this study was to investigate how people with Parkinson´s disease experience an intervention of optimizing their own medical treatment through digitally…
  • 2023 International Congress

    Influence of Cognitive Function on Obstacle-Crossing Performance in People with Parkinson’s Disease: A Cross-Sectional Study

    HH. Hsu, RY. Wang, NC. Yeh, PL. Wong, CW. Hung (Taipei, Taiwan)

    Objective: This study investigated the influence of cognitive function on obstacle crossing performance in people with Parkinson's disease (PD). Background: Obstacle-crossing is a complex motor…
  • 2023 International Congress

    White matter hyperintensities associated with impulse control disorders in Parkinson’s disease

    G. Hernadi, G. Perlaki, M. Kovacs, D. David, G. Orsi, J. Janszky, N. Kovacs (Pécs, Hungary)

    Objective: Given the limited number of non-motor features studied in this context, our aim was to reveal the potential association between the severity of white…
  • 2023 International Congress

    Making the invisible visible: A qualitative interview study on the impact of young onset Parkinson’s disease on (ex-)partners

    W. Kapelle, A. Geerlings, I. Mutsaers, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

    Objective: This study aimed to explore the impact of having an (ex-)partner with young onset Parkinson’s disease (YOPD) on daily life. Background: People with YOPD…
  • 2023 International Congress

    Evaluating continuous monitoring in Parkinson’s disease through real-world, device-reported outcomes.

    G. Rigas, N. Kostikis, A. Ntanis, F. Kanellos, K. Tsamis, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)

    Objective: This work presents an analysis of real-world, device-reported outcomes from patients in Greece, following a 6-month, continuous telemonitoring paradigm for Parkinson's disease. Results show…
  • 2023 International Congress

    Development and validation of a new wearable device for the differential diagnosis of resting tremor

    M. de Maria, F. Aracri, C. Calomino, M. Crasà, J. Buonocore, B. Vescio, A. Quattrone (Catanzaro, Italy)

    Objective: To develop a new easy-to-use wearable device to estimate the muscular contraction pattern of rest tremor (RT) using inertial data. Background: The RT pattern…
  • « Previous Page
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley